Macrolide Pharmaceuticals picks up $22 mln

Newton, Massachusetts-based Macrolide Pharmaceuticals, a new company focused on developing novel antibiotics, has secured $22 million in Series A funding. The investors were Novartis Venture Fund, Gurnet Point Capital, Roche Ventures, and SROne.

Principia Biopharma Inks $12.5M

Principia Biopharma Inc., a biopharmaceutical company focused on immunology, autoimmune diseases, and oncology, has raised $12.5 million. Investors include New Leaf Venture Partners, OrbiMed Advisors, Morgenthaler Ventures, SROne and Mission Bay Capital.

PE HUB Community

Join the 12523 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget